Author

N. Ramachandra

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Approach:deep learning· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

K. Pradhan· 2 shared A. Aboumohamed· 1 shared A. Fromowitz· 1 shared A. Kulkarni· 1 shared A. Tischer· 1 shared A. Verma· 1 shared B. A. Gartrell· 1 shared C. Chetal· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

K. Pradhan

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Broad de-regulated U2AF1 splicing is prognostic and augments leukemic transformation via protein arginine methyltransferase activation

M. Venkatasubramanian, L. Schwartz, N. Ramachandra, J. Bennett, K. R. Subramanian, S. Gordon-Mitchell, A. Fromowitz, K. Pradhan, D. Shechter, S. Sahu, D. Heiser, P. Scherle, X. Chen, C. Chetal, A. Kulkarni, , N. G. Salomonis

The paper identifies a splicing mechanism in AML independent of mutations, showing it drives poor prognosis and can be targeted with PRMT5 inhibition.

bioRxiv · Feb 4, 2024Cancer Biology

Functional succinate dehydrogenase deficiency and loss of ascorbic acid transporter SLC23A1 are pathognomonic adverse features of clear cell renal cancer

R. K. Aggarwal, Y. Zou, R. A. Luchtel, K. Pradhan, N. Ashai, N. Ramachandra, J. Albanese, J.-i. Yang, X. Wang, S. Aluri, S. Gordon, V. Machha, A. Tischer, A. Aboumohamed, B. A. Gartrell, , N. Shenoy

This paper identifies functional succinate dehydrogenase deficiency and loss of SLC23A1 as common adverse features in clear cell renal cell carcinoma, with implications for diagnosis and treatment.

bioRxiv · Jul 5, 2020Cancer Biology